Markets

Interventional Oncology Global Market – Forecast to 2029

NEW YORK, 22 December 2022 /PRNewswire/ —

Interventional oncology (IO) is a rapidly growing field of cancer treatment that uses minimally invasive procedures performed under image guidance to diagnose and treat patients with liver, kidney, lung, brain and spine, prostate, and other cancers.

Read the full report: https://www.reportlinker.com/p05877741/?utm_source=PRN

Instead of removing tumors through open surgical procedures, these image-guided procedures can be performed instead of or in combination with other cancer treatments to provide truly comprehensive care. The advantage of these methods is that IO has much less effect on the body compared to conventional procedures.

According to IQ4I analysis, the global interventional oncology market is expected to grow at a high level from 2022 to 2029. Some of the factors driving the market are the increasing incidence of cancer, the increasing geriatric population, and the growing use of minimally invasive procedures . Factors such as technological advancements in interventional oncology and expansion in new markets are opportunities for the market. Similarly, side effects and risks associated with its use, lack of awareness and lack of trained professionals are limiting the market growth, while the availability of alternative treatments and strict regulatory guidelines are a threat to the market growth.

The interventional oncology market is segmented based on products, applications, end users, and geography. The interventional oncology market based on products is segmented as ablation and embolization. The embolization segment is expected to grow at a mid-single from 2022 to 2029. The ablation segment is the fastest growing double-digit from 2022 to 2029.

Based on product type, the global ablation market is sub-segmented into radiofrequency ablation, microwave ablation, cryoablation, HIFU, and others (irreversible electroporation and MRI-guided laser ablation). Among these, microwave ablation is expected to grow at a double-digit rate from 2022 to 2029. The HIFU segment is the fastest growing among high-teens from 2022. Embolization global market based on procedure is sub-segmented into transarterial radioembolization (TARE) )/selective internal radiation therapy (SIRT ), transarterial chemoembolization (TACE), drug-eluting beads transarterial chemoembolization (DEB-TACE), and transarterial embolization (TAE)/blank embolization. Among procedures, TARE/SIRT is expected to grow at a mid-single from 2022 to 2029. Bland/TAE is the fastest growing at mid-single from 2022 to 2029.

Based on application, the global interventional oncology market is segmented into liver cancer, kidney cancer, lung cancer, brain and spine cancer, prostate cancer, and others. Among these applications, the liver cancer segment is expected to grow at mid-single from 2022 to 2029. Brain and spine cancer is the fastest growing double digit from 2022. The application market is further sub-segmented into ablation and embolization applications.

The ablation market is segmented into liver cancer, kidney cancer, lung cancer, brain and spine cancer, prostate cancer, and others. Among these applications, the liver cancer segment is expected to grow at a double-digit rate from 2022 to 2029. Brain and spine cancer is the fastest growing segment at a double-digit rate from 2022 to 2029.

Embolization global market based on application is segmented into liver cancer, lung cancer, prostate cancer and others. Among embolization applications, the liver cancer segment is expected to grow at mid-single from 2022 to 2029.

The global end-user interventional oncology market is segmented into hospitals, ambulatory surgical centers (ASCs), and academics and research institutes. Among end users, hospital is expected to grow at a high single from 2022 to 2029. Ambulatory surgery center is the fastest growing at a high single from 2022 to 2029.

The interventional oncology market by region is segmented as North America (USA and the rest of the North America), Europe (Germany, France, Italyand the rest of Europe), Asia-Pacific region (China, Japan, Australiaand the rest of APAC), and the rest of the world (BrazilThe rest of LATAM and Middle East & others). North America expected to be at a high single from 2022 to 2029. Mainly due to rising incidences of cancer, growing demand for minimally invasive surgeries, favorable reimbursements, product launches and availability of qualified personnel. That Asia-Pacific region is the fastest growing region with a double-digit growth from 2022 to 2020. Owing to the increasing geriatric population and increasing incidence of cancer, increasing expenditure on healthcare facilities, increasing awareness of interventional oncology and low-cost surgeries are driving the market.

The global interventional oncology market is a consolidated market with the top 6 players occupying a large share of the market and hence all the existing players in this market are involved in developing new and advanced therapies to maintain their market share. Some of the major players in the interventional oncology market include Medtronic Plc (Ireland), Sirtex Medical (China), Boston Scientific Corporation (USA), Angiodynamics (USA), Guerbet (France), Merit Medical System (USA), Siemens healthineers, Inc. (Variant) (Germany.), Terumo Corporation (Japan), Johnson & Johnson (USA), AngioDynamics, Inc. (USA) and Monteris Medical (USA).

The report provides an in-depth market analysis of the above segments across the following regions:
• North America
o the United States
o The rest of North America

• Europe
island Germany
island France
island Italy
o The rest of Europe

• Asia-Pacific region
island Japan
island China
island Australia
o Rest of APAC

• Rest of the World (RoW)
island Brazil
o Rest of LATAM
o The Middle East and other

Read the full report: https://www.reportlinker.com/p05877741/?utm_source=PRN

About Report link
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________
Contact Clare: [email protected]
United States: (339)-368-6001
International: +1 339-368-6001

Cision

Cision

See original content:https://www.prnewswire.com/news-releases/interventional-oncology-global-market—forecast-to-2029-301708269.html

SOURCE Report link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button